← Human Trials & Peer-Reviewed Studies
[Evaluation of the organoleptic characteristics of an oral nutritional supplement designed specifically for the cancer patient].
Plain-language guide to PMID 36880737 (2023): double-blind randomized controlled trial of Copper (Supplement).
Key Facts
- PMID
- 36880737
- Journal
- Nutricion hospitalaria
- Year
- 2023
- Study type
- Randomized Controlled Trial
- Authors
- Morato Martínez M et al. (5 authors)
- DOI
- 10.20960/nh.04362
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Copper (Supplement).
Objectives: to evaluate the organoleptic characteristic of different prototypes of oral nutritional supplements specifically designed for cancer patients.
Method: cross-sectional, randomized, double-blind pilot clinical study in patients with any type of cancer, with or without oncological treatment, who tasted five ONS prototypes with different flavors (brownie, tropical, pineapple, tomato and ham) and different sensory qualities in order to evaluate their organoleptic characteristics (color, smell, taste, residual taste, texture and density) through a specific questionnaire.
Why It Was Studied
Introduction: oral nutritional supplements (ONS) are nutritional therapies used to treat malnutrition in cancer patients, therefore, innovation in these treatments, from nutrients to sensory quality, is essential to ensure their consumption.
Who Took Part
Results: thirty patients aged 67.5 ± 11.2 years and body mass index (BMI) of 22.3 ± 3.52 kg/m2 were evaluated.
How the Study Was Run
In design terms this was a randomized, double-blind and pilot study.
The participants were allocated by chance, so the Copper (Supplement) group and the comparison group should start out alike.
Neither the participants nor the staff measuring them knew who was on Copper (Supplement), so expectations could not easily colour the readings.
It is described as a pilot, a small early test of whether a larger Copper (Supplement) study would be practical.
What Was Measured
Topics PubMed links to this paper include Cross-Sectional Studies, Malnutrition, Sensation, Dietary Supplements and Neoplasms.
Author keywords: Suplementos nutricionales orales. Cáncer. Desnutrición. Características organolépticas.
What This Means in Plain Language
The paper is a randomized, double-blind and pilot study of Copper (Supplement).
The publication is from 2023 (Nutricion hospitalaria), a journal based in Spain.
More context: the Copper (Supplement) compound page, all human trials.
Our Notes on the Compound
Copper (Supplement): The active site of cytochrome c oxidase is described as containing copper ions that are essential for electron transfer.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.